 |
56 Diseases |  |
8 Trials |
|
8 Trials |  |
1230 News |  |
| «12345678910 |
- | Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
Enrollment closed: Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria (clinicaltrials.gov) - Jan 6, 2013
P2, N=40, Active, not recruiting, Sponsor: University of Michigan
Enrolling by invitation --> Active, not recruiting
- Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
Enrollment open: Kuvan in People With Schizophrenia and Schizoaffective Disorder (clinicaltrials.gov) - Dec 18, 2012
P1/2, N=60, Recruiting, Sponsor: New York State Psychiatric Institute
Enrolling by invitation --> Active, not recruiting Not yet recruiting --> Recruiting
- |||||||||| Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
New P3 trial: EMR 700773_510: Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan (clinicaltrials.gov) - Nov 20, 2012
P3, N=90, Completed, Sponsor: Merck KGaA
- | Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
New P1/2 trial: Kuvan in People With Schizophrenia and Schizoaffective Disorder (clinicaltrials.gov) - Oct 11, 2012
P1/2, N=60, Recruiting, Sponsor: New York State Psychiatric Institute
- || Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
Trial completion: Open-Label Extension Study of Kuvan for Autism (clinicaltrials.gov) - Aug 30, 2012
P2/3, N=41, Completed, Sponsor: The Children's Health Council
Not yet recruiting --> Recruiting Enrolling by invitation --> Completed
- Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
New P3 trial: The Effects of Sapropterin Dihydrochloride Supplementation on in Vivo Redox Status in Patients With Classical PKU (clinicaltrials.gov) - Jul 24, 2012
P3, N=0, Withdrawn, Sponsor: Stanford University
- |||| Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
Trial completion: ENDURE: Response to Kuvan (clinicaltrials.gov) - Jul 19, 2012
P4, N=59, Completed, Sponsor: Merck KGaA
Enrolling by invitation --> Completed Recruiting --> Completed
- | Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
New P4 trial: Effects of Kuvan on Melatonin Secretion (clinicaltrials.gov) - Jun 10, 2012
P4, N=12, Enrolling by invitation, Sponsor: University of Southern California
- ||||| Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
Enrollment closed: PKU-015: Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU (clinicaltrials.gov) - May 10, 2012
P3, N=230, Active, not recruiting, Sponsor: BioMarin Pharmaceutical
Recruiting --> Completed Recruiting --> Active, not recruiting
- Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
Biomarker, Enrollment change: Tetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders (clinicaltrials.gov) - Dec 8, 2011
P=N/A, N=10, Completed, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Active, not recruiting N=20 --> 10
- Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
Biomarker, Trial completion: Tetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders (clinicaltrials.gov) - Dec 8, 2011
P=N/A, N=10, Completed, Sponsor: The University of Texas Health Science Center, Houston
N=20 --> 10 Recruiting --> Completed
- Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
Trial completion, FDG PET: Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy (clinicaltrials.gov) - Nov 15, 2011
P=N/A, N=6, Completed, Sponsor: Children's Hospital of Philadelphia
Recruiting --> Completed Recruiting --> Completed
- Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
Enrollment open: Endothelial Facilitation in Alzheimer's Disease (clinicaltrials.gov) - Nov 1, 2011
P2, N=10, Recruiting, Sponsor: University of Massachusetts, Worcester
Recruiting --> Completed Not yet recruiting --> Recruiting
- Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
New P2/3 trial: Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension (clinicaltrials.gov) - Oct 18, 2011
P2/3, N=42, Completed, Sponsor: Fundacion Clinic per a la Recerca Biom
- Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
New P2 trial: Endothelial Facilitation in Alzheimer's Disease (clinicaltrials.gov) - Sep 21, 2011
P2, N=10, Recruiting, Sponsor: University of Massachusetts, Worcester
- | Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
New P1/2 trial: Study of Kuvan Treatment in Adults With GTPCH Deficiency (clinicaltrials.gov) - Aug 28, 2011
P1/2, N=12, Completed, Sponsor: University of Utah